• Strategy
  • Payers
  • AI
  • Cybersecurity
  • Device Development
  • Studies/Published Research
  • Ethics
  • Regulatory
  • Digital Biomarkers
  • Data Science
  • Companion Diagnostics
  • Clinical Care
  • Digital Therapeutics
  • Academic Research
  • Virtual Reality
  • RWE
  • Digital Endpoints
  • Medical Devices (Class II and Class III)
  • Commercialization
  • Clinical Trials
  • Drug-Device Combinations
  • SaMD
  • Remote Patient Monitoring
  • Patient Engagement
  • Profiles/Q&A

Veranex Announces Appointments of New CEO and COO

Article

Veranex announced the appointment of industry veteran Tom Daulton as chief executive officer (CEO). David Dockhorn, who previously served in this role, is assuming the newly created role of chief operating officer (COO).

Read more about the appointments here.

Related Videos
Related Content
FDA Approves Two of Scientia Vascular’s Neurovascular Catheters

FDA Approves Two of Scientia Vascular’s Neurovascular Catheters

May 7th 2024
Articles

The catheters approved by the FDA include the Plato 17, a DMSO-compatible microcatheter, and the Socrates 38, an aspiration catheter specifically designed for treating ischemic strokes.

FDA Approves Abbott’s Dissolving Stent System for Chronic Limb-Threatening Ischemia in Arteries Below the Knee

FDA Approves Abbott’s Dissolving Stent System for Chronic Limb-Threatening Ischemia in Arteries Below the Knee

May 1st 2024
Articles

Treatment marks the first dissolving stent approved in the United States for treating chronic limb-threatening ischemia in arteries below the knee.

Image Credit: Adobe Stock Images/Dr_Microbe

Expanse Ice Receives FDA 510(k) Clearance for ICE Aspiration System for Peripheral Arterial, Venous Systems

April 25th 2024
Articles

Technology designed to effectively address blood clots by combining capabilities of larger devices with smaller catheters.

ImageCredit: Adobe Stock Images/dima_oris

Evergreen Theragnostics Raises $26M in Capital to Aid Commercialization Efforts for the Ga-68 DOTATOC Diagnostic Kit

April 17th 2024
Articles

Capital also expected to assist the advancement of Evergreen's radiopharmaceutical discovery pipeline into clinical trials.

Philips Respironics Finalizes Consent Decree Regarding Business Operations in the US with Department of Justice, FDA

Philips Respironics Finalizes Consent Decree Regarding Business Operations in the US with Department of Justice, FDA

April 10th 2024
Articles

Decree comes amid the FDA’s 2021 inspection of Philips’ Murrysville facility and the subsequent voluntary recall of its sleep and respiratory care devices.

FDA Approves Abbott’s i-STAT TBI Whole Blood Rapid Test to Assess Patients for Concussions at Bedside

FDA Approves Abbott’s i-STAT TBI Whole Blood Rapid Test to Assess Patients for Concussions at Bedside

April 2nd 2024
Articles

The concussion test, which shows results after 15 minutes, can help evaluate patients up to 24 hours after injury, company says.

© 2024 MJH Life Sciences

All rights reserved.